APA citiranje

Pennig, J., Scherrer, P., Gissler, M. C., Anto-Michel, N., Hoppe, N., Füner, L., . . . Willecke, F. (2019). Glucose lowering by SGLT2-inhibitor empagliflozin accelerates atherosclerosis regression in hyperglycemic STZ-diabetic mice. Sci Rep.

Citação norma Chicago

Pennig, Jan, et al. "Glucose Lowering By SGLT2-inhibitor Empagliflozin Accelerates Atherosclerosis Regression in Hyperglycemic STZ-diabetic Mice." Sci Rep 2019.

MLA citiranje

Pennig, Jan, et al. "Glucose Lowering By SGLT2-inhibitor Empagliflozin Accelerates Atherosclerosis Regression in Hyperglycemic STZ-diabetic Mice." Sci Rep 2019.